AAAAAA
Results: 1-25/194
Authors:
DENARDO GL
ODONNELL RT
OLDHAM RK
DENARDO SJ
Citation: Gl. Denardo et al., A REVOLUTION IN THE TREATMENT OF NON-HODGKINS-LYMPHOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 213-223
Authors:
BERGHELLA AM
PELLEGRINI P
CONTASTA I
DELBEATO T
ADORNO D
Citation: Am. Berghella et al., BCL-2 AND DRUGS USED IN THE TREATMENT OF CANCER - NEW STRATEGIES OF BIOTHERAPY WHICH SHOULD NOT BE UNDERESTIMATED, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 225-237
Authors:
DENARDO GL
DENARDO SJ
LAMBORN KR
GOLDSTEIN DS
LEVY NB
LEWIS JP
OGRADY LF
RAVENTOS A
KROGER LA
MACEY DJ
MCGAHAN JP
MILLS SL
SHEN S
Citation: Gl. Denardo et al., LOW-DOSE, FRACTIONATED RADIOIMMUNOTHERAPY FOR B-CELL MALIGNANCIES USING I-131 LYM-1 ANTIBODY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 239-254
Authors:
HORNICK JL
SHARIFI J
KHAWLI LA
HU PS
BIELA BH
MIZOKAMI MM
YUN A
TAYLOR CR
EPSTEIN AL
Citation: Jl. Hornick et al., A NEW CHEMICALLY-MODIFIED CHIMERIC TNT-3 MONOCLONAL-ANTIBODY DIRECTEDAGAINST DNA FOR THE RADIOIMMUNOTHERAPY OF SOLID TUMORS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 255-268
Authors:
NADKARNI JJ
PERAMBAKAM SM
RATHORE VB
AMIN KM
PARIKH PM
NARESH KN
ADVANI SH
Citation: Jj. Nadkarni et al., EXPRESSION OF ADHESION MOLECULES IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - AN ANALYSIS IN LYMPHOID COMPARTMENTS - PERIPHERAL-BLOOD, BONE-MARROW AND LYMPH-NODE, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 269-274
Authors:
NAKAMURA K
MATSUNAGA K
Citation: K. Nakamura et K. Matsunaga, SUSCEPTIBILITY OF NATURAL-KILLER (NK) CELLS TO REACTIVE OXYGEN SPECIES (ROS) AND THEIR RESTORATION BY THE MIMICS OF SUPEROXIDE-DISMUTASE (SOD), CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 275-290
Citation: 7TH CONFERENCE ON RADIOIMMUNODETECTION AND RADIOIMMUNOTHERAPY OF CANCER - OCTOBER 15-17, 1998 - PRINCETON, NEW-JERSEY - ABSTRACTS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 299-329
Authors:
OLDHAM RK
Citation: Rk. Oldham, UNTITLED, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 141-141
Authors:
WALTER MR
BORDENS R
NAGABHUSHAN TL
WILLIAMS BRG
HERBERMAN RB
DINARELLO CA
BORDEN EC
TROTTA PP
PESTKA S
PFEFFER LM
Citation: Mr. Walter et al., REVIEW OF RECENT DEVELOPMENTS IN THE MOLECULAR CHARACTERIZATION OF RECOMBINANT ALPHA-INTERFERONS ON THE 40TH ANNIVERSARY OF THE DISCOVERY OF INTERFERON, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 143-154
Authors:
SCHACHTER J
RAKOWSKY E
SULKES A
ADLER A
Citation: J. Schachter et al., A SEQUENTIAL 4-DRUG CHEMOTHERAPY AND BIOTHERAPY WITH INTERFERON-ALPHAAND GM-CSF - AN INNOVATIVE PROTOCOL FOR THE TREATMENT OF METASTATIC MELANOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 155-164
Authors:
DILLMAN RO
NAYAK SK
BARTH NM
DELEON C
SCHWARTZBERG LS
SPITLER LE
CHURCH C
OCONNOR AA
BEUTEL LD
Citation: Ro. Dillman et al., CLINICAL-EXPERIENCE WITH AUTOLOGOUS TUMOR-CELL LINES FOR PATIENT-SPECIFIC VACCINE THERAPY IN METASTATIC MELANOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 165-176
Authors:
ILGAN S
YANG DJ
HIGUCHI T
ZARENEYRIZI F
KIM EE
PODOLOFF DA
Citation: S. Ilgan et al., IMAGING TUMOR FOLATE RECEPTORS USING (IN)-I-111-DTPA-METHOTREXATE, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 177-184
Authors:
KAMEI H
KOIDE T
KOJIMA T
HASHIMOTO Y
HASEGAWA M
Citation: H. Kamei et al., INHIBITION OF CELL-GROWTH IN CULTURE BY QUINONES, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 185-188
Authors:
KOIDE T
KOJIMA T
KAMEI H
Citation: T. Koide et al., ANTITUMOR EFFECT OF GOLD AS REVEALED BY GROWTH SUPPRESSION OF CULTURED CANCER-CELLS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 189-192
Authors:
WIMER BM
Citation: Bm. Wimer, IMPLICATIONS OF THE ANALOGY BETWEEN RECOMBINANT CYTOKINE TOXICITIES AND MANIFESTATIONS OF HANTAVIRUS INFECTIONS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 193-207
Authors:
NIAKAN B
Citation: B. Niakan, A MECHANISM OF THE SPONTANEOUS REMISSION AND REGRESSION OF CANCER, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 209-210
Authors:
OLDHAM RK
Citation: Rk. Oldham, TREATMENT OF DRUG-RESISTANCE - BIOTHERAPY OR CHEMOTHERAPY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 69-70
Authors:
OLDHAM RK
REID WK
PREISLER HD
BARNETT D
Citation: Rk. Oldham et al., A PHASE-I AND PHARMACOKINETIC STUDY OF CBT-1 AS A MULTIDRUG-RESISTANCE MODULATOR IN THE TREATMENT OF PATIENTS WITH ADVANCED CANCER, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 71-80
Authors:
JUVEKAR AS
AMONKAR AJ
DCRUZ AK
SAIKAIA T
PRADHAN S
Citation: As. Juvekar et al., CHEMOSENSITIVITY OF ADVANCED LARYNX-CARCINOMA CELLS IN-VITRO AND SIGNIFICANCE OF MULTIDRUG-RESISTANCE MARKERS IN THESE TUMORS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 81-87
Authors:
PELLEGRINI P
BERGHELLA AM
DELBEATO T
MACCARONE D
CASCIANI CU
ADORNO D
Citation: P. Pellegrini et al., DISEASE STAGE PROGNOSTIC INDEXES IN THE EARLY CLINICAL SCREENING OF COLORECTAL-CANCER PATIENTS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 89-98
Authors:
WIMER BM
Citation: Bm. Wimer, IMMUNOSUPPRESSIVE APPLICATIONS OF PHA AND OTHER PLANT MITOGENS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 99-107
Authors:
WIMER BM
Citation: Bm. Wimer, PHA FOR APLASTIC ANEMIAS - THE ALPHA BUT NOT THE OMEGA OF MITOGEN THERAPIES, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 109-120
Authors:
ZARKOVIC N
KALISNIK T
LONCARIC I
BOROVIC S
MANG S
KISSEL D
KONITZER M
JURIN M
GRAINZA S
Citation: N. Zarkovic et al., COMPARISON OF THE EFFECTS OF VISCUM-ALBUM LECTIN ML-1 AND FRESH PLANT-EXTRACT (ISOREL) ON THE CELL-GROWTH IN-VITRO AND TUMORIGENICITY OF MELANOMA B16F10, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 121-131
Authors:
STEFFENS MG
KRANENBORG MHGC
BOERMAN OC
ZEGWAARTHAGEMEIER NEM
DEBRUYNE FMJ
CORSTENS FHM
OOSTERWIJK E
Citation: Mg. Steffens et al., TUMOR RETENTION OF RE-186-MAG3, IN-111-DTPA AND I-125 LABELED MONOCLONAL-ANTIBODY G250 IN NUDE-MICE WITH RENAL-CELL CARCINOMA XENOGRAFTS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 133-139
Authors:
WEINER G
Citation: G. Weiner, BISPECIFIC ANTIBODY THERAPY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 1-1